APA

Hoppenbrouwers K., Kanra G., Roelants M., Ceyhan M., Vandermeulen C., Yurdakök K., Silier T., Dupuy M., Pehlivan T., Ozmert E. & Desmyter J. (19990527). Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.

Chicago

Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakök K, Silier T, Dupuy M, Pehlivan T, Ozmert E and Desmyter J. 19990527. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.

Harvard

Hoppenbrouwers K., Kanra G., Roelants M., Ceyhan M., Vandermeulen C., Yurdakök K., Silier T., Dupuy M., Pehlivan T., Ozmert E. and Desmyter J. (19990527). Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.

MLA

Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakök K, Silier T, Dupuy M, Pehlivan T, Ozmert E and Desmyter J. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine. 19990527.